Why the study?
Does cloxacillin prophylaxis prevent experimental Staphylococcus aureus endocarditis in rats infected with tolerant versus nontolerant strains?
Does cloxacillin prophylaxis prevent experimental Staphylococcus aureus endocarditis in rats infected with tolerant versus nontolerant strains?
In a rat model of S. aureus endocarditis, bacterial tolerance to cloxacillin significantly reduced the efficacy of prophylaxis, requiring the addition of gentamicin for complete protection.
Answers are grounded in this paper and cite their sources.
Cloxacillin tolerance may reduce prophylaxis efficacy in experimental S. aureus endocarditis; hypothesis-generating for human regimens and leaves open adjunctive strategies.
The role of tolerance was investigated in the prophylaxis of Staphylococcus aureus endocarditis with cloxacillin in rats. The effect of a single dose of 500 mg/kg, two 80 mg/kg doses 3 h apart, and a single dose of 80 mg/kg, alone or in combination with a single dose of 4 mg of gentamicin/kg, were compared for a tolerant strain of S. aureus and its isogenic nontolerant variant. At all dosages, cloxacillin was significantly less effective in preventing endocarditis with the tolerant strain than with the nontolerant variant. With the high dose of cloxacillin or two successive lower doses, nearly complete protection could be obtained against the nontolerant strain. However, for the tolerant strain, only the combination of cloxacillin and gentamicin afforded almost complete protection. For the tolerant strain, no serum bactericidal activity was found at the time of bacterial challenge after an injection of any dose of cloxacillin. These results suggest that the in vitro phenomenon of tolerance may have relevance in vivo.
No takes yet. Share an insight, caveat, or question.
Voorn et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: